Lumos Pharma, Inc. (LUMO)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 59.76M |
| Enterprise value | -40.26M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.19k |
| Price/book (mrq) | 0.63 |
| Enterprise value/revenue | -805.15 |
| Enterprise value/EBITDA | 1.06 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -59.93% |
| S&P500 52-week change 3 | 27.77% |
| 52-week high 3 | 36.72 |
| 52-week low 3 | 6.80 |
| 50-day moving average 3 | 8.85 |
| 200-day moving average 3 | 10.31 |
Share statistics
| Avg vol (3-month) 3 | 18.49k |
| Avg vol (10-day) 3 | 25.77k |
| Shares outstanding 5 | 8.36M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 4.99M |
| % held by insiders 1 | 28.48% |
| % held by institutions 1 | 34.50% |
| Shares short (14 Nov 2021) 4 | 59.17k |
| Short ratio (14 Nov 2021) 4 | 3.81 |
| Short % of float (14 Nov 2021) 4 | 0.93% |
| Short % of shares outstanding (14 Nov 2021) 4 | 0.71% |
| Shares short (prior month 14 Oct 2021) 4 | 82.23k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 18 Mar 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2020 |
| Most-recent quarter (mrq) | 29 Sept 2021 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -63,664.00% |
Management effectiveness
| Return on assets (ttm) | -16.40% |
| Return on equity (ttm) | -25.58% |
Income statement
| Revenue (ttm) | 50k |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | 168k |
| EBITDA | -31.36M |
| Net income avi to common (ttm) | -27.2M |
| Diluted EPS (ttm) | -3.27 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 100.65M |
| Total cash per share (mrq) | 12.04 |
| Total debt (mrq) | 637k |
| Total debt/equity (mrq) | 0.68 |
| Current ratio (mrq) | 17.47 |
| Book value per share (mrq) | 11.26 |
Cash flow statement
| Operating cash flow (ttm) | -30.8M |
| Levered free cash flow (ttm) | 6.98M |
© 2021 Yahoo. All rights reserved.
